Cytoreductive surgery in the era of targeted molecular therapy.

Transl Androl Urol · 2015 · PMC4708236 · PMID 26815334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

utilizing the SEER (Surveillance, Epidemiology and End Results)—Medicare dataset from 2001-2008 showed a decreasing trend in the utilization of CN in the targeted therapy era suggesting a potential uncertainty in survival benefit of CN with newer available targeted agents ( 12 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.